# A Randomized, Phase I Study of DNA Vaccine OC-007 as a Booster Dose of COVID-19 Vaccine

> **NCT05685953** · PHASE1 · COMPLETED · sponsor: **Matti Sällberg** · enrollment: 16 (actual)

## Conditions studied

- COVID-19 Respiratory Infection
- COVID-19 Vaccine Adverse Reaction

## Interventions

- **BIOLOGICAL:** DNA vaccine OC-007
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05685953
- **Lead sponsor:** Matti Sällberg
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-08
- **Primary completion:** 2024-03-13
- **Final completion:** 2024-03-13
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2024-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05685953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05685953, "A Randomized, Phase I Study of DNA Vaccine OC-007 as a Booster Dose of COVID-19 Vaccine". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05685953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*